top of page

FDA-IND Application for Expanded Use & NDC Registrations 01/01/2022

  • Jan 25, 2022
  • 1 min read

Updated: Feb 1, 2024

FDA-IND Application for Intermediate Size Group Population Expanded Access:

1. Outline of Materials

2. FDA-IND-1571: Expanded Access Form

3. Financial Interests of Investigator Form

4. Statement of Investigators Form

5. Principal Investigator & Co-PI CV

6. Statement of Purpose, Background

7. Proposed Research Project Background

8. Current Provisional Patent Claims

9. Clinical Design, Aims, Goals & Budget

10. Research Validation Brain Imaging

11. Research Consent, IND Disclosures

12. Formula: Pharmacology-Toxicology Data

13. Current Thesis Research Outline

14. Commercial Pitch Deck with Societal Impact Statement, Referenced Background, Commercial Potentials Real Time Revenue Model


ree

ree

ree

ree

 
 
 

Comments


Neuroscience Institute on Addiction  Recovery

  • Facebook
  • YouTube

© 2023-2030 Website & Brand is a Registered USPTO for All Copyrights,

Trademarks, Patents & International Publications 

All Rights Reserved

USPTO-FDA-NIH-NCBI-NLM-PUBMED-CMS-DHS-DOD-DARPA

Vetted Registered Clearance Identification Numbers:

USGOV-SAM-SBIR: JAC6JJKYAF77JJ / DUN#: 013428223 / CAGE: 8TT10 / NAICS: 541611 

NATIONAL PROVIDER NUMBERS (NPIs): 1467193623/1083355119

Due Diligence Disclosure Reviews, Alignments & Match Verifications:

UNITED STATES GOVERNMENT: FDA. SBIR, NIH, USPTO, FEDERAL NIH-NIDA RFA, DoD CAGE-NAICS, GRANTS.GOV,

DUN & BRADSTREET, STATE LLC-501c3 REGISTRATION, TOP TEIR INSURANCE CARRIER CONTRACT CREDENTIALED,

ETHEREUM, FACEBOOK-META-MULTIVERSE-NFT, PAYPAL & VENMO CORPORATE, BANK OF AMERICA CORPORATE ZELLE,

AMAZON VETTED PARTNERSHIP BUSINESS

bottom of page